Assignee
THERAPEUTIC SOLUTIONS INT INC
US·6 granted patents·47 pending applications·3 citations·filing 2016–2024
Top patents by PatentIndex Score
53 records- 0190US11504410B2Neuroprotection and neuroregeneration by pterostilbene and compositions thereofTHERAPEUTIC SOLUTIONS INT INC·Filed 2021·Granted Nov 22, 2022·2 cites·19 claims
- 0281US11759495B2Upregulation of therapeutic T regulatory cells and suppression of suicidal ideations in response to inflammation by administration of nutraceutical compositions alone or combined with minocyclineTHERAPEUTIC SOLUTIONS INT INC·Filed 2021·Granted Sep 19, 2023·1 cites·19 claims
- 0366US2024076679A1Gene silencing therapy of acute respiratory disorderTHERAPEUTIC SOLUTIONS INT INC·Filed 2023·Application pending·0 cites
- 0464US12011462B2Stimulation of mesenchymal stem cell therapeutic activities by T regulatory cellsTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Granted Jun 18, 2024·0 cites·12 claims
- 0564US2024366677A1Aneurysm Treatment by ExosomesTHERAPEUTIC SOLUTIONS INT INC·Filed 2024·Application pending·0 cites
- 0663US2024156862A1Treatment of chronic obstructive pulmonary disease with myeloid derived suppressor cellsTHERAPEUTIC SOLUTIONS INT INC·Filed 2023·Application pending·0 cites
- 0763US2024307446A1Generation and Utility of B Cell Subsets for Treatment of Chronic Obstructive Pulmonary DiseaseTHERAPEUTIC SOLUTIONS INT INC·Filed 2024·Application pending·0 cites
- 0863US2024034996A1Gene modified ipsc derived cellular compositions for regeneration and immune modulationTHERAPEUTIC SOLUTIONS INT INC·Filed 2023·Application pending·0 cites
- 0963US2023226119A1Umbilical cord derived regenerative and immune modulatory stem cell populationsTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 1062US2024241119A1Prediction of stem cell therapy responsiveness by quantification of pre-existing b regulatory cellsTHERAPEUTIC SOLUTIONS INT INC·Filed 2024·Application pending·0 cites
- 1162US2024082356A1Treatment of copd by stimulation of stem cell mobilizationTHERAPEUTIC SOLUTIONS INT INC·Filed 2023·Application pending·0 cites
- 1262US2024050485A1Treatment of chronic obstructive pulmonary disease by mesenchymal stem cell apoptotic bodies and compositions thereofTHERAPEUTIC SOLUTIONS INT INC·Filed 2023·Application pending·0 cites
- 1361US2023301938A1Treatment of covid-19 associated cognitive dysfunction by nutraceutical preparationsTHERAPEUTIC SOLUTIONS INT INC·Filed 2023·Application pending·0 cites
- 1461US2023364148A1Inhibition and reversion of chronic obstructive pulmonary disease (copd) by endothelial cell regenerationTHERAPEUTIC SOLUTIONS INT INC·Filed 2023·Application pending·0 cites
- 1561US2024269148A1Enhancement of Anti-Angiogenic Cancer Immunotherapy by Abortogenic AgentsTHERAPEUTIC SOLUTIONS INT INC·Filed 2024·Application pending·0 cites
- 1660US2024226172A9Mesenchymal stem cell therapy of epilepsy and seizure disordersTHERAPEUTIC SOLUTIONS INT INC·Filed 2023·Application pending·0 cites
- 1760US2024216472A1Enhanced efficacy of tolerogenic vaccinationTHERAPEUTIC SOLUTIONS INT INC·Filed 2024·Application pending·0 cites
- 1859US2024091269A1Treatment of bipolar disorder using mesenchymal stem cells and modification of mesenchymal stem cellsTHERAPEUTIC SOLUTIONS INT INC·Filed 2023·Application pending·0 cites
- 1957US11951146B2Stimulation of NK cell activity by using a combination of broccoli, Nigella Sativa, Green Tea, and pterostilbene alone and together with metforminTHERAPEUTIC SOLUTIONS INT INC·Filed 2021·Granted Apr 9, 2024·0 cites·16 claims
- 2057US2022267730A1Ex vivo generation of immunocytes recognizing brother of the regulator of imprinted sites (boris) expressing cancer stem cellsTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 2157US2022306994A1Chimeric cells comprising dendritic cells and endothelial cells resembling tumor endotheliumTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 2256US2022298491A1Pluripotent stem cell derived dendritic cells and engineered dendritic cells for cancer immunotherapyTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 2356US2023047535A1Induction of neurogenesis using umbilical cord derived mesenchymal stem cells and derivatives thereofTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 2456US2023057957A1Umbilical cord mesenchymal stem cells for treatment of chronic obstructive pulmonary disease and lung degenerationTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 2556US2023277598A1Treatment of trauma associated cognitive dysfunction using mesenchymal stem cell apoptotic bodies and compositions thereofTHERAPEUTIC SOLUTIONS INT INC·Filed 2023·Application pending·0 cites
- 2656US2022235325A1Stimulation of dendritic cell activity by homotaurine and analogues thereofTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 2755US2022370561A1Lithium as a monotherapy and/or stem cell adjuvant therapy for pulmonary fibrosisTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 2855US2023010501A1Treatment of parkinson's disease by immune modulation and regenerative meansTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 2955US2023192901A1Induction of concurrent pulmonary immune modulation and regeneration by protein mediated conjugation of immune regulatory cells with endogenous progenitor cellsTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 3054US2023085607A1Ivermectin compositions for treatment of covid-19THERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 3154US2022323547A1Amelioration and Treatment of Opioid AddictionTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 3254US2023107484A1Reduction of neutrophil extracellular trap formation by mesenchymal stem cells and their exosomesTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 3353US2022143123A1Prevention of Pathological Coagulation in COVID-19 and other Inflammatory ConditionsTHERAPEUTIC SOLUTIONS INT INC·Filed 2021·Application pending·0 cites
- 3453US2022403330A1Compositions capable of stimulating immunity towards tumor blood vesselsTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 3553US2022096542A1Augmentation of natural killer cell activity and induction of cytotoxic immunity using leukocyte lysate activated allogeneic dendritic cells: stemvacsTHERAPEUTIC SOLUTIONS INT INC·Filed 2021·Application pending·0 cites
- 3653US2022023237A1Additive and/or synergistic combinations of metformin with nutraceuticals for the prevention, inhibition and treatment of sars-cov-2 and associated covid-19THERAPEUTIC SOLUTIONS INT INC·Filed 2021·Application pending·0 cites
- 3753US2022249551A1Stimulation of natural kill cell memory by administration of dendritic cellsTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 3852US11957727B2Prevention of neuroinflammation associated memory loss using nutraceutical compositionsTHERAPEUTIC SOLUTIONS INT INC·Filed 2021·Granted Apr 16, 2024·0 cites·10 claims
- 3951US2023057356A1Enhancement of umbilical cord mesenchymal stem cell therapeutic activity by stimulators of t regulatory cells and/or cells expressing cd73THERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 4051US2022362341A1Treatment of major depressive disorder by low dose interleukin-2THERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 4151US2022370499A1Immunotherapies for targeting of tumor vasculatureTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 4251US2022280574A1Therapeutic monocytes for prevention of suicidal ideationTHERAPEUTIC SOLUTIONS INT INC·Filed 2022·Application pending·0 cites
- 4351US2022395540A1Treatment of covid-19 lung injury using umbilical cord plasma based compositionsTHERAPEUTIC SOLUTIONS INT INC·Filed 2021·Application pending·0 cites
- 4450US9682047B2Augmentation of oncology immunotherapies by pterostilbene containing compositionsTHERAPEUTIC SOLUTIONS INT INC·Filed 2016·Granted Jun 20, 2017·0 cites·8 claims
- 4550US2022193170A1Nutraceutical Reduction Prevention and/or Reversion of Multiple SclerosisTHERAPEUTIC SOLUTIONS INT INC·Filed 2021·Application pending·0 cites
- 4650US2021128638A1Cellular, organ, and whole-body rejuvenation utilizing cord blood plasma and pterostilbeneTHERAPEUTIC SOLUTIONS INT INC·Filed 2020·Application pending·0 cites
- 4750US2022175701A1Treatment of major depressive disorder and suicidal ideations through stimulation of hippocampal neurogenesis utilizing plant-based approachesTHERAPEUTIC SOLUTIONS INT INC·Filed 2021·Application pending·0 cites
- 4849US2022193127A1Immunotherapy for opioid addictionTHERAPEUTIC SOLUTIONS INT INC·Filed 2021·Application pending·0 cites
- 4948US2022125852A1Protection and regeneration of neurological function by using stem cellsTHERAPEUTIC SOLUTIONS INT INC·Filed 2021·Application pending·0 cites
- 5046US2023333117A1Methods of determining risk of suicide by immunological assessmentTHERAPEUTIC SOLUTIONS INT INC·Filed 2021·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when THERAPEUTIC SOLUTIONS INT INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →